用户名:
密 码:
注册
|
忘记密码?
首 页
药品信息
药品检索
全部药品
适应症分类
热门药品
专利信息
专利检索
专利权人导航
专利权人分组导航
分类查询
IPC导航
热门检索
专利分析
概况
申请趋势分析
申请人分析
发明人分析
IPC分析
项目文档
项目
个人项目
文档
个人文档
企业文档
公共文档
标签
互动
特色功能
广州科技订制咨询
特色资讯
医药新闻
帮助中心
关于本软件
药品
文档
专利
新闻
所有专利
选择导航
专利权人导航
专利权人分组导航
分类导航
专利权人分组导航
辉瑞(2955)
诺华(2198)
阿斯利康(1998)
施维雅(1619)
Teva(1273)
南新(1189)
罗氏(455)
第一制药三共(335)
强生(130)
清华大学(3)
专利信息
Translation Company
查询条件
展开筛选条件
所有数据
查询
分析
排序
公开日
公开号
申请日
申请号
中文标题
英文标题
降序
升序
翻到页码
标题
标题2
专利权人
发明人
附图
摘要
摘要2
优先权号
IPC
专利类型
首页
上页
4
5
6
7
8
9
10
11
12
13
14
下页
尾页
共
269414
条记录, 当前第9/26942页。
公开号
公开日
申请号
申请日
1.
US2014080811A1
2014/3/20
US201313779511
2013/2/27
专利标题
:Treatment of Alzheimer's Disease Using Compounds that Reduce the Activity of Non-Selective CA++ Activated ATP-Sensitive Cation Channels Regulatd by SUR1 Channels
专利权人
:
REMEDY PHARMACEUTICALS INC [US]
;
REMEDY PHARMACEUTICALS INC [US]
;
NSC antagonists are disclosed as useful in the treatment of dementia, in delaying the onset of dementia, and in the prevention of dementia. Dementia so treated may be, for example, Alzheimer's Disease (AD). NSC antagonists for treating dementia such as AD may be administered alone, a) in combination with other drugs used for treating dementia, b) in combination with drugs that stabilize or increase blood plasma glucose levels, or with both a) and b). Pharmaceutical compositions, dosage forms, an...
2.
US2014079781A1
2014/3/20
US201314087388
2013/11/22
专利标题
:PHARMACEUTICAL COMPOSITIONS
专利权人
:
SCHNEIDER PETER [DE]
;
NEUHAUS THORSTEN [DE]
;
BOEHRINGER INGELHEIM INT [DE]
;
The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and pioglitazone, processes for the preparation thereof, and their use to treat certain diseases.
3.
US2014080778A1
2014/3/20
US201214115923
2012/5/14
专利标题
:USE OF SECNIDAZOLE IN TREATMENT OF DENTAL INFECTIONS
专利权人
:
DEFRANCE PIERRE-MARIE [FR]
;
MADECA [FR]
;
The invention relates to the combination of secnidazole with an antibiotic of the macrolide family, preferably azithromycin 11, for oral treatment of dental infections, which enables a considerable reduction in the length of treatment and the doses administered in comparison with the conventional treatment.
4.
WO2014040280A1
2014/3/20
WO2012CN81422
2012/9/14
专利标题
:COCRYSTAL OF PIPERACILLIN SODIUM AND SULBACTAM SODIUM AND PREPARATION METHOD THEREOF, AS WELL AS PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND USES THEREOF
专利权人
:
BEIJING XINTIANYU TECHNOLOGY DEV CO LTD [CN]
;
WANG HAIYONG [CN]
;
LI JING [CN]
;
Provided in the present invention are a cocrystal of piperacillin sodium and sulbactam sodium and a preparation method therefor, as well as pharmaceutical compositions containing the same and uses thereof in treating infections caused by drug-resistant bacteria, such as a "super bacterium" producing NDM-1 and the like. The cocrystal of piperacillin sodium and sulbactam sodium contains diffraction angles of 14.24 DEG , 16.58 DEG , 16.79 DEG , 17.77 DEG , 19.20 DEG , 20.21 DEG , 20.39 DEG , 23.06 ...
5.
US2014079777A1
2014/3/20
US201314083983
2013/11/19
专利标题
:DRY POWDER VANCOMYCIN COMPOSITIONS AND ASSOCIATED METHODS
专利权人
:
SAVARA INC [US]
;
Dry powder vancomycin compositions and methods for administering and preparing such compositions are provided.
6.
US2014079647A1
2014/3/20
US201314089355
2013/11/25
专利标题
:CEFDINIR AND CEFIXIME FORMULATIONS AND USES THEREOF
专利权人
:
BILGIC MAHMUT [TR]
;
The invention features pharmaceutically acceptable salts of cefdinir, including primary, secondary, and tertiary amine salts of cefdinir, and preparation methods, and pharmaceutical compositions including cefdinir. The invention also features water dispersible pharmaceutical dosage forms including cefdinir as active agent and methods for preparing the dosages. The invention also features tablet forms of cefixime characterized in that the tablets are in effervescent form. The invention also featu...
7.
WO2014040239A1
2014/3/20
WO2012CN81283
2012/9/12
专利标题
:CEFUROXIME SODIUM CRYSTAL COMPOUND AND COMPOSITION POWDER INJECTION THEREOF
专利权人
:
HAINAN WEI KANG PHARMACEUTICAL QIANSHAN COMPANY LTD [CN]
;
Disclosed is a cefuroxime sodium crystal compound and a composition powder injection thereof, wherein the crystal form of cefuroxime sodium is amorphous and the preparation method thereof is as follows: reacting cefuroxime acid with sodium bicarbonate to obtain a solution and adding active carbon to discolor it, and then quick-freezing for 2 hours at -40-50 DEG C after sterile filtration using a filter membrane, followed by vacuum drying. The components of the cefuroxime sodium composition powde...
8.
AU2012311235A1
2014/3/20
AU20120311235
2012/9/19
专利标题
:A composition and method for treating an autoimmune disease
专利权人
:
REDHILL BIOPHARMA LTD
;
A combination of antibiotics including rifabutin, clarithromycin and clofazimine for the treatment of an autoimmune disease such as multiple sclerosis and related diseases. In a further aspect, there is provided a composition comprising a combination of two or more antibiotic agents for the treatment of an autoimmune disease, said two or more antibiotic agents selected from rifabutin, clofazimine, and at least one macrolide.
9.
WO2014042604A1
2014/3/20
WO2013TR00288
2013/9/6
专利标题
:CLINDAMYCIN PHOSPHATE, SALICYLIC ACID AND TEA TREE OIL COMBINATIONS
专利权人
:
IMUNEKS FARMA MAC SANAYI VE TICARET A S [TR]
;
PISAK IBRAHIM MUSTAFA ISKENDER [TR]
;
PISAK MEHMET NEVZAT [TR]
;
SELAMOGLU MEHMET LEVENT [TR]
;
BINGOL SEMRA [TR]
;
The present invention relates to the topical compositions comprising clindamycin phosphate, salicylic acid and tea tree oil
10.
WO2014042598A1
2014/3/20
WO2013SG00403
2013/9/17
专利标题
:DRUG THERAPY FOR CANCER, INCLUDING MULTIPLE MYELOMA
专利权人
:
UNIV SINGAPORE [SG]
;
There is provided a pharmaceutical composition for use in therapy comprising a compound of formula (IA) and a compound of formula (IIA). There is also provided the use of the disclosed pharmaceutical composition in the manufacture of a medicament for treating cancer, including a clonal plasma cell malignancy such as multiple myeloma. The multiple myeloma may be relapsed, refractory or bortezomib resistant multiple myeloma. There is also provided the use of a compound of Formula (IA) in the manuf...
首页
上页
4
5
6
7
8
9
10
11
12
13
14
下页
尾页
共
269414
条记录, 当前第9/26942页。
当前查询条件: 所有数据
查询范围
在当前结果中查询
!
专利类型
发明
实用新型
外观设计
!
公开号
CN1234
!
申请号
CN1234
!
专利标题
扩展
PHARMA
!
专利权人
扩展
pfizer
发明人
!
申请日
yyyymmdd
!
公开日
yyyymmdd
优先权号
!
摘要
扩展
PHARMA
IPC
A01B
下载范围
下载第
到
条记录。
下载内容
题录信息
专利全文